The Dino Guglielmelli, Jeff Kanter Conversation on the Healthy America Initiative and Longevity Industry, Peptides etc.
Jeff Kanter0:01
That was it.
Jeff Kanter0:02
Because once he said, you're not going to give me Secret Service, you're not going to let me be in your primary.
Jeff Kanter0:07
They him over, he said, okay, then I'm going to run as an independent because they were messing with the wrong guy.
Jeff Kanter0:12
Well, when you knew that wasn't going to end up anywhere, then when he connected with Trump and here all of our people been working with Trump way before my time.
Jeff Kanter0:20
I had nothing to do with any of that stuff.
Jeff Kanter0:23
And all of this came together.
Jeff Kanter0:26
Everyone's God's hand is behind this.
Jeff Kanter0:27
I've heard that over and over again.
Jeff Kanter0:30
And.
Dino Guglielmelli0:30
I truly.
Jeff Kanter0:31
Believe.
Dino Guglielmelli0:31
That, Jeff.
Dino Guglielmelli0:32
I truly believe that because this does not happen.
Dino Guglielmelli0:35
It doesn't happen without a higher power bringing energy to this.
Dino Guglielmelli0:39
It doesn't.
Jeff Kanter0:40
Everyone leaves, this event goes.
Jeff Kanter0:42
It's like I knew every one of these people from another life somehow.
Jeff Kanter0:46
I met a hundred people that were my best friend.
Jeff Kanter0:50
Within 20 minutes we were best friends.
Jeff Kanter0:53
And so much collaboration across all of these things are going on is absolutely unreal that you would ever imagine.
Jeff Kanter1:00
And that was before the opportunity zone showed up.
Jeff Kanter1:03
Now that those showed up, we've got physical locale where we're going to get.
Jeff Kanter1:07
And here's the great amazing coincidence, I'm doing these Shark Tank events, right?
Jeff Kanter1:11
So part of that was that wasn't even our original idea, but one of the first people that came on board was funding these pre FDA approval companies.
Jeff Kanter1:19
And so he said, well, let's get them in front of these people.
Jeff Kanter1:22
So when they're ready to get to that next tier, we get these bigger players that will give them millions of dollars when I can only give them hundreds of thousands to get them to this first threshold.
Jeff Kanter1:30
And so we built out it, we got Cantor Fitzgerald, design board, Jerome Corsey.
Jeff Kanter1:35
We have some unbelievable deep pocket investors.
Jeff Kanter1:38
I mean the one organization we had their minimum deals, 300 million bucks.
Jeff Kanter1:42
So they won't even look at your deal.
Jeff Kanter1:44
I got guys that we need like 500,000 bucks.
Jeff Kanter1:46
They said, don't even bring the guy in front of me if he doesn't meet at least 2 million.
Jeff Kanter1:50
We didn't want to talk to that person.
Jeff Kanter1:52
So we've got people every strata of fundraising needs.
Jeff Kanter1:56
So here these opportunity zones show up.
Jeff Kanter1:58
Well, what does that require?
Jeff Kanter1:59
Someone to buy the tax credit to fund this black person's business?
Jeff Kanter2:02
Yeah, I got a whole shitload of people can't wait to invest money.
Jeff Kanter2:06
So all of these little things,.
Dino Guglielmelli2:07
This is.
Jeff Kanter2:08
Gravitated and then the spark got flicked in July and, and it took off.
Dino Guglielmelli2:14
So I just had a doctor in my office who is part of Maha.
Dino Guglielmelli2:18
He meets with rfk and he has thousands of cancer patients that he has cured naturally.
Dino Guglielmelli2:26
Now we don't.
Dino Guglielmelli2:28
I'm never one to say, oh, gosh, Western medicine isn't good for you.
Dino Guglielmelli2:33
Sure it is.
Dino Guglielmelli2:33
There's certain instances where you need it and you should have it.
Dino Guglielmelli2:36
And the doctor.
Dino Guglielmelli2:37
You need.
Jeff Kanter2:37
That doctor,.
Dino Guglielmelli2:38
Right?
Jeff Kanter2:39
Got a gunshot wound, having a heart attack.
Jeff Kanter2:42
I don't know where else I'd rather be,.
Dino Guglielmelli2:44
Right?
Jeff Kanter2:44
If I got diabetes, I might as well go to a third world,.
Dino Guglielmelli2:47
Right?
Dino Guglielmelli2:48
But he was sitting.
Dino Guglielmelli2:49
And you probably know him, but I'm not going to mention his name on here.
Dino Guglielmelli2:52
He would have to do that, right?
Dino Guglielmelli2:54
But.
Dino Guglielmelli2:54
But he.
Dino Guglielmelli2:54
We're going to work together because he wants me to make all of his products, and I'm going to make all of his price because I believe in him so much.
Dino Guglielmelli3:02
And he sits there and says the can't see word all the time.
Dino Guglielmelli3:05
And I'm like, doc, don't you ever feel like, you know, you're up against the wall?
Dino Guglielmelli3:10
He goes, no, I'm part of Maha, and I can do this now.
Dino Guglielmelli3:14
I'm like, you can?
Dino Guglielmelli3:16
Okay, I'm into it.
Dino Guglielmelli3:18
I said, but how is it that you're getting through this?
Dino Guglielmelli3:20
He goes, look at.
Dino Guglielmelli3:21
I'm enhancing traditional medical practices with what I'm doing.
Dino Guglielmelli3:26
I'm not replacing it.
Dino Guglielmelli3:28
I'm just making it so people don't have to do the traditional one that may have other damages that happen over time.
Dino Guglielmelli3:33
I'm just healing them faster.
Dino Guglielmelli3:36
And that's his narrative.
Dino Guglielmelli3:37
And that narrative works for me.
Dino Guglielmelli3:38
I don't care, because I truly believe that there.
Dino Guglielmelli3:41
That we need everything in the toolbox.
Dino Guglielmelli3:44
You know, we're all different.
Dino Guglielmelli3:46
Everybody who says, you know, we're all made the same.
Dino Guglielmelli3:48
No, we are not.
Dino Guglielmelli3:50
As soon as we're slapped on the butt, we are different.
Dino Guglielmelli3:53
As soon as that slap happens, you know, whether you're, you know, it come from money or you're in poverty or you're, you know, there's so many issues that go.
Dino Guglielmelli4:03
Involved in that, right?
Dino Guglielmelli4:04
We.
Dino Guglielmelli4:04
We are not equal.
Dino Guglielmelli4:06
And so we have to be very, very targeted with each individual.
Dino Guglielmelli4:10
And what was interesting about is when I'm sitting there, I'm talking to him, he goes, you're coming with me.
Dino Guglielmelli4:15
We're going to D.C. together, Dino, because I believe in what you're doing.
Dino Guglielmelli4:19
Because my part of the process to create stuff, like, I'm the creator, I'm the developer, I'm the one that's Making it all.
Dino Guglielmelli4:25
I'm the one that makes sure it's compliant, it's within the guidelines.
Dino Guglielmelli4:29
He's the one that's going, this is what it's for.
Dino Guglielmelli4:32
This is the protocols, this is where I'm using in clinical treatments, this is what I'm doing in treatment centers.
Dino Guglielmelli4:36
And so, you know, they need me and I need them.
Dino Guglielmelli4:41
Just like the patient needs you, they need me, they need him.
Dino Guglielmelli4:44
They don't just need that one doctor that's telling them go down this pathway.
Dino Guglielmelli4:48
They need to open up their, their vision.
Dino Guglielmelli4:52
They have to open up, you know, the conversation with more people instead of closing it down.
Dino Guglielmelli4:59
And I'm so glad you're doing this because that's what's going to open it up.
Jeff Kanter5:02
You know what is really compelling about this, we at the very beginning, a lot of these key people, and you won't be stunned to know, hear this.
Jeff Kanter5:09
Well, you know, when I come to one of these events, you know, I get paid an honorarium and then I get a per diem and I'm going to get my airfare covered and my food covered and my hotel covered.
Jeff Kanter5:20
And we said, really?
Jeff Kanter5:21
And interestingly, at this event, you're going to pay to come, you're going to pay for your own Fairfair and you're going to pay for your own lodging and you're not going to be a keynote speaker.
Jeff Kanter5:31
You're going to actually be on a panel with two other people who just told me the same thing you just told me.
Jeff Kanter5:37
And, and everyone said that's going to be so hard to make happen because you're dealing with these incredible egos.
Jeff Kanter5:41
Yeah, lo and behold, what we're doing is so successful, they're battling it out to come and be on a panel again because when was the chance that that keynote got to sit in a room with 20 other keynote people?
Jeff Kanter5:53
So that's where the secret sauces come into this and why we cap our attendance to between 100 and maybe 200 people and a little bit more in D.C. because we don't want anything but that.
Jeff Kanter6:05
The Elon Musk meeting with the Steve Jobs people.
Jeff Kanter6:09
And that's the only way we're going to get anywhere.
Jeff Kanter6:11
But the opportunity zone became the ability to meet the masses because we've already been laying in chapters to do what we do as a public facing event like in Michigan and whatever.
Jeff Kanter6:24
So we're going to keep doing that where we're going to do the same methodology and one of our kick ass secret sauces, because my one partner owns all the technology to do all those robo calls and all the rest of that stuff.
Jeff Kanter6:37
That's exactly how we're rolling this out because we're sitting on that exact same tool and we're treating this like a presidential campaign, the way we can blast out to everybody.
Jeff Kanter6:46
So this event we, we have Brett Bol coming, he's known as America's encouragement coach and he's launching the Healthy kids program.
Jeff Kanter6:54
And he's going to be, while we're at our event in Nashville, he's going to be at the schools networking with all the kids and stuff and he'll be speaking at our event.
Jeff Kanter7:02
And then we're going to do a whole blown out event on that at the Hula bowl in January in Daytona, because one of the other guys that's developed this sits on the board of the Hula Bowl.
Jeff Kanter7:12
So we're just going to just be everywhere, all over.
Jeff Kanter7:15
And that's really the only way we're going to make this be successful is to kill them with a zillion paper cuts.
Jeff Kanter7:22
Because everybody's going to who.
Jeff Kanter7:23
Who cares about their kids and health and, and having.
Jeff Kanter7:26
And as a good example, like one supplement guy says, well, you know, maybe I should be the exclusive supplement.
Jeff Kanter7:31
Hey, like you said, I don't know.
Jeff Kanter7:33
I got to imagine some of the guys got, maybe he's got a clone of your supplements, maybe he's got a little variations, but who knows?
Jeff Kanter7:39
We don't totally know which is the best.
Jeff Kanter7:42
So why don't we let them all take a shot like McDonald's, Burger King, Wendy's.
Dino Guglielmelli7:46
Yeah,.
Jeff Kanter7:46
And let the consumers figure it out and other doctors will vet it as well.
Jeff Kanter7:50
And they're going to help to sort out the better, like aaa.
Jeff Kanter7:53
They're going to figure out what are the better ones.
Jeff Kanter7:55
And even still, let's say the two of them end up being really, really good.
Jeff Kanter7:58
Well, guess what?
Jeff Kanter7:59
There's 330 million people.
Jeff Kanter8:01
How's your one company going to service everybody?
Jeff Kanter8:04
So there's more than enough business for every player in the field to participate.
Dino Guglielmelli8:09
Free market.
Dino Guglielmelli8:10
Free market economies is what this is out.
Dino Guglielmelli8:14
And that's what creates competition.
Dino Guglielmelli8:15
It keeps prices down.
Dino Guglielmelli8:18
Honest.
Dino Guglielmelli8:19
You have to be ethical, you know, I mean, as soon as you're going into a monopoly, that's the reason why we don't have monopolies in this country.
Dino Guglielmelli8:26
Right.
Jeff Kanter8:28
But they sort of de facto formed, like you said, with pharmaceuticals, like they sort of became monopolies in their own little perverted.
Dino Guglielmelli8:35
Way.
Jeff Kanter8:36
But because we're so diffused, I don't Want to chain.
Jeff Kanter8:40
In these various opportunities, though, there's a freestanding compounding pharmacy that I may have won in every community, but they're all owned by the local black family.
Jeff Kanter8:48
Just picking a type of demographic in each community.
Jeff Kanter8:53
All separate, but they may be working at that same protocol.
Jeff Kanter8:56
We have a guy right now that's doing stuff in the cancer treatment, and he's got this technology to compound certain formulas.
Jeff Kanter9:03
Well, he would license that to each one.
Jeff Kanter9:06
So they might do a similar thing at retail, but yet they're all separate.
Jeff Kanter9:09
So there's no chain or monopolies that way.
Jeff Kanter9:12
Come and go, rise and fall, and the.
Jeff Kanter9:15
And the market will sort it out very, very well.
Dino Guglielmelli9:18
Yep, exactly.
Jeff Kanter9:20
It really is exciting.
Jeff Kanter9:21
You're going to be so jazzed, Dino, especially when you walk away from this event.
Jeff Kanter9:25
And, and I'm going to tell you right now, you, I built up some expectations.
Jeff Kanter9:29
They're going to be small compared to what's going to happen when you actually attend.
Jeff Kanter9:35
You undersold this whole event.
Dino Guglielmelli9:39
Well, I, I can already imagine if you're doing that.
Dino Guglielmelli9:42
I'm already, you know, because my, my bar is pretty low on the expectation of where this is going, you know, in the next five years.
Dino Guglielmelli9:50
Where does this go in preventative medicine?
Dino Guglielmelli9:53
And it's.
Dino Guglielmelli9:53
I really believe it's all about peptides because, you know, people don't understand how peptides work.
Dino Guglielmelli9:58
And you probably do because you're sitting at the table with experts and everything.
Jeff Kanter10:02
To some degree.
Dino Guglielmelli10:03
So they're messengers, right?
Dino Guglielmelli10:05
And so basically, you take a peptide, it then it sends out a signal to another cell that has a receptor of that signal, same message.
Dino Guglielmelli10:14
It's waiting for that message to that other cell.
Dino Guglielmelli10:17
It communicates to that cell.
Dino Guglielmelli10:19
Now that cell has the message.
Dino Guglielmelli10:20
It releases a signal that now connects to the rest of the cells.
Dino Guglielmelli10:24
And what happens is we lose those peptides as we age, we lose the communication.
Dino Guglielmelli10:29
And when I'm.
Dino Guglielmelli10:30
When I'm on stage, I talk about this.
Dino Guglielmelli10:32
When you've been married for 30 years and you stop communicating with each other, what happens to your relationship?
Dino Guglielmelli10:37
Well, it's the same thing that happens to your body when your cells stop communicating with each other.
Dino Guglielmelli10:42
It breaks down.
Dino Guglielmelli10:44
It has problems.
Dino Guglielmelli10:45
It gets, you know, gets rusty.
Dino Guglielmelli10:48
Right?
Dino Guglielmelli10:49
That's oxidative stress.
Dino Guglielmelli10:50
Okay?
Dino Guglielmelli10:51
There's only two peptides been scientifically proven to release telomerase enzymes, which is the telomeres connected to our chromosomes.
Dino Guglielmelli11:01
And when they elongate, that elongates life.
Dino Guglielmelli11:03
That's longevity.
Dino Guglielmelli11:05
There's a study that was done in 2000 I think it's 2019 in Stanford that showed that when enzymatic telomeres activated, they elongated the telomeres 24%.
Dino Guglielmelli11:19
24% And it increased the rat's life 2.4%.
Dino Guglielmelli11:24
In studies by Stanford, there's only two peptides that say it.
Dino Guglielmelli11:29
Now you can go on the Internet and you'll hear all the time, long gates telomeres, long gates telomeres.
Dino Guglielmelli11:33
So there's only two that scientific.
Dino Guglielmelli11:35
It's GHKCU and epitelink.
Dino Guglielmelli11:37
Epitalin is patil is the pineal gland peptide and GHKCU is copper.
Dino Guglielmelli11:42
Those are the only two scientifically proven to do it.
Dino Guglielmelli11:44
But yet you'll see everywhere.
Dino Guglielmelli11:46
Right.
Dino Guglielmelli11:46
And, and that's what we have to get away from.
Dino Guglielmelli11:50
We have to.
Jeff Kanter11:50
Get.
Dino Guglielmelli11:50
Away to a real science, you know, real science based acknowledgment of product and, and then work on that as a community.
Dino Guglielmelli12:01
Right.
Dino Guglielmelli12:01
I don't, I don't care if I'm the only guy making copper peptide.
Dino Guglielmelli12:04
I don't care if I'm the only guy doing epitalin peptide.
Dino Guglielmelli12:07
But I want to make sure that it's been done right, that it's delivered in the right dosing that is high quality, 98.5% pure or higher, and that it's ethical.
Dino Guglielmelli12:17
Right.
Dino Guglielmelli12:18
If that's the case, bring on 100 people making it, I'm, I'll be there to help them, guide them and how to do it, no problem.
Dino Guglielmelli12:26
But if there's somebody out there not doing it right and they're getting all of the attention, all we're doing is hurting ourselves.
Jeff Kanter12:34
Yeah, no question.
Jeff Kanter12:35
And that's a big part of this too.
Jeff Kanter12:36
Most of our, we've been doing this in our day job prior because my partner ran a bunch of trade associations and I'm in Scottsden a lot of them now because I developed the health plans that go inside of those.
Jeff Kanter12:47
But that's kind of what he did.
Jeff Kanter12:49
He did like the National Home Appraisers association.
Jeff Kanter12:52
Well that they all began to subscribe to this code of ethics.
Jeff Kanter12:58
So if you're going to get this person come to your home, wouldn't it make more sense to get one that's accredited by this association that has a list of ethics than that straight person who's making whatever claim?
Jeff Kanter13:08
Maybe they're honest, they could very well be.
Jeff Kanter13:11
But this just kind of validates it.
Jeff Kanter13:13
So we have like the National Health Care Sharing association.
Jeff Kanter13:16
So we have a lot of these health sharing organizations a part of that because they started running problems because right after they got okayed by Obamacare there were a lot of great ones because that's who was out there already.
Jeff Kanter13:28
But guess what, who showed up unethical ones and they began to burn the reputation of health sharing in general because it was like you said, who made the news, the one that was robbing people, not the one that was doing a great job and never let anyone down.
Jeff Kanter13:42
So that's kind of what's been forming as a parallel within what we're doing is all these people that come to the table that are experts, they're helping us develop these kind of guiding bodies to not pick or choose winners but to kind of lay out the guardrails so that if you can fit within this spectrum like you just described it, so you'll be a perfectly a part of that element of it because that's exactly what we want to make happen because that's the only way we're going to survive against the onslaught that's about to come from Pfizer and everybody else.